![]() |
|||||||||||||||||||||||||||||||||
| About Us | |||||||||||||||||||||||||||||||||
| Team | |||||||||||||||||||||||||||||||||
Employees: Second Sight employs a team of over 70 employees dedicated to the success of the company and its mission. The team is comprised of exceptional R&D, manufacturing, and logistics personnel as well as seasoned regulatory, clinical and quality experts. Directors: Second Sight's executive board consists of six members who are veterans of the active implantable medical device and ophthalmic device sectors. These include: Alfred E. Mann, Chairman Aaron Mendelsohn, board member Gregg Williams, board member Robert Greenberg, MD, PhD, President and CEO Thomas Fogarty, board member | |||||||||||||||||||||||||||||||||
| Patients | |||||||||||||||||||||||||||||||||
| Careers | |||||||||||||||||||||||||||||||||
| Contact Us | |||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||
| © 2006 Second Sight. | |||||||||||||||||||||||||||||||||
Collaborators: Second Sight collaborates with a variety of institutional research partners including:
Additionally, Second Sight receives significant financial support from the National Eye Institute of the National Institutes of Health. |
|||||||||||||||||||||||||||||||||